The bcr–abl gene created by this inter-chromosomal exchange encodes one of two fusion proteins, p185 and p210, that display elevated and dysregulated TK activity, and forms the fundamental mechanism underlying CML positive cells. This evidence concerns the gene TKT and chronic myelogenous leukemia, BCR-ABL1 positive.